103
Views
13
CrossRef citations to date
0
Altmetric
Liver and Biliary Tract

Quantification of hepatitis C amino acid substitutions 70 and 91 in the core coding region by real-time amplification refractory mutation system reverse transcription-polymerase chain reaction

, , PhD , MD, , , , , , & show all
Pages 872-877 | Received 05 Feb 2009, Published online: 21 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shingo Nakamoto, Tatsuo Kanda, Fumio Imazeki, Shuang Wu, Makoto Arai, Keiichi Fujiwara & Osamu Yokosuka. (2011) Simple assay based on restriction fragment length polymorphism associated with IL28B in chronic hepatitis C patients. Scandinavian Journal of Gastroenterology 46:7-8, pages 955-961.
Read now

Articles from other publishers (12)

MOTOYUKI KOHJIMA, MIHO KUROKAWA, MUNECHIKA ENJOJI, TSUYOSHI YOSHIMOTO, TSUKASA NAKAMURA, TOMOKO OHASHI, KUNITAKA FUKUIZUMI, NAOHIKO HARADA, YUSUKE MURATA, KAZUHISA MATSUNAGA, MASAKI KATO, KAZUHIRO KOTOH & MAKOTO NAKAMUTA. (2016) Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C. Experimental and Therapeutic Medicine 11:5, pages 1781-1787.
Crossref
Shingo Nakamoto, Fumio Imazeki, Makoto Arai, Shin Yasui, Masato Nakamura, Yuki Haga, Reina Sasaki, Tatsuo Kanda, Hiroshi Shirasawa & Osamu Yokosuka. (2015) Effect of Hepatitis C Virus Genotype 1b Core and NS5A Mutations on Response to Peginterferon Plus Ribavirin Combination Therapy. International Journal of Molecular Sciences 16:9, pages 21177-21190.
Crossref
Min-Suk Jeong & Dae-Ro Ahn. (2015) A microwell plate-based multiplex immunoassay for simultaneous quantitation of antibodies to infectious viruses. The Analyst 140:6, pages 1995-2000.
Crossref
Zhongjie Hu, Ying Liu, Lixia Qiu, Zuopeng Fan, Wei Nie, Shan Liang & Ronghua Jin. (2014) Quantitation of substitutions at amino acid 70 in hepatitis C virus genotype 1b. Virology Journal 11:1.
Crossref
Motokazu Mukaide, Masaya Sugiyama, Masaaki Korenaga, Kazumoto Murata, Tatsuya Kanto, Naohiko Masaki & Masashi Mizokami. (2014) High-throughput and sensitive next-generation droplet digital PCR assay for the quantitation of the hepatitis C virus mutation at core amino acid 70. Journal of Virological Methods 207, pages 169-177.
Crossref
Kenichi Tadokoro, Mariko Kobayashi, Fumitaka Suzuki, Chie Tanaka, Toshikazu Yamaguchi, Makoto Nagano, Toru Egashira & Hiromitsu Kumada. (2013) Comparative quantitative analysis of hepatitis C mutations at amino acids 70 and 91 in the core region by the Q-Invader assay. Journal of Virological Methods 189:1, pages 221-227.
Crossref
Tatsuo Kanda, Shingo Nakamoto, Makoto Arai, Tatsuo Miyamura, Shuang Wu, Keiichi Fujiwara & Osamu Yokosuka. (2013) Natural interferon-beta plus ribavirin therapy led to sustained virological response after seven unsuccessful courses of anti-viral treatment in a chronic hepatitis C patient. Clinical Journal of Gastroenterology 6:2, pages 160-163.
Crossref
Motoyuki Kohjima, Munechika Enjoji, Tsuyoshi Yoshimoto, Ryoko Yada, Tatsuya Fujino, Yoko Aoyagi, Nobuyoshi Fukushima, Kunitaka Fukuizumi, Naohiko Harada, Masayoshi Yada, Masaki Kato, Kazuhiro Kotoh, Manabu Nakashima, Naoya Sakamoto, Yasuhito Tanaka & Makoto Nakamuta. (2013) Add-on therapy of pitavastatin and eicosapentaenoic acid improves outcome of peginterferon plus ribavirin treatment for chronic hepatitis C. Journal of Medical Virology 85:2, pages 250-260.
Crossref
Chung-Feng Huang, Jee-Fu Huang, Jeng-Fu Yang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Liang-Yen Wang, Suh-Hang Hank Juo, Ku-Chung Chen, Wan-Long Chuang, Hsing-Tao Kuo, Chia-Yen Dai & Ming-Lung Yu. (2012) Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin. Journal of Hepatology 56:1, pages 34-40.
Crossref
Tomokazu Kawaoka, Hiroshi Aikata, Daisuke Miyaki, Eisuke Murakami, Takahiro Azakami, Shintaro Takaki, Yuko Nagaoki, Yoshimasa Hashimoto, Yoshio Katamura, Akira Hiramatsu, Koji Waki, Nobuhiko Hiraga, Daiki Miki, Masataka Tsuge, Michio Imamura, Yoshiiku Kawakami, Shoichi Takahashi, Hidenori Ochi, Hirotaka Tashiro, Hideki Ohdan & Kazuaki Chayama. (2011) Eradication of hepatitis C virus genotype 1 after liver transplantation by interferon therapy before surgery: Report of three patients with analysis of interleukin-28 polymorphism, hepatitis C virus core region and interferon-sensitivity determining regio. Hepatology Research 41:11, pages 1126-1131.
Crossref
T. Kanda, F. Imazeki, Y. Yonemitsu, S. Mikami, N. Takada, T. Nishino, M. Takashi, A. Tsubota, K. Kato, N. Sugiura, A. Tawada, S. Wu, T. Tanaka, S. Nakamoto, R. Mikata, M. Tada, T. Chiba, T. Kurihara, M. Arai, K. Fujiwara, F. Kanai & O. Yokosuka. (2010) Quantification of hepatitis C virus in patients treated with peginterferon‐alfa 2a plus ribavirin treatment by COBAS TaqMan HCV test. Journal of Viral Hepatitis 18:7.
Crossref
Yuko Inoue, Naoki Hiramatsu, Tsugiko Oze, Takayuki Yakushijin, Kiyoshi Mochizuki, Kazuto Fukuda, Eiji Mita, Yoshimichi Haruna, Atsuo Inoue, Yasuharu Imai, Atsushi Hosui, Takuya Miyagi, Yuichi Yoshida, Tomohide Tatsumi, Shinichi Kiso, Tatsuya Kanto, Akinori Kasahara, Tetsuo Takehara & Norio Hayashi. (2011) Amino acid substitution in the core protein has no impact on relapse in hepatitis C genotype 1 patients treated with peginterferon and ribavirin. Journal of Medical Virology 83:3, pages 419-427.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.